Michael W. Kalb - 01 Jan 2024 Form 3 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role: Executive Vice President & CFO
Signature: /s/ Michael W. Kalb
Issuer symbol: CPRX
Transactions as of: 01 Jan 2024
Net transactions value: $0
Form type: 3
Filing time: 03 Jan 2024, 17:18:47 UTC
Previous filing: 12 May 2023
Next filing: 25 Nov 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	CPRX	Common Stock, par value $0.001 per share						0	01 Jan 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	CPRX	Options to purchase common stock							01 Jan 2024	Common Stock	257,214	$16.81	Direct	F1
holding	CPRX	Restricted Stock Units							01 Jan 2024	Common Stock	35,693		Direct	F1, F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Derivative Securities vest in five annual tranches beginning on January 1, 2025.
F2	Shares of common stock will be delivered to the Reporting Person upon vesting.
F3	Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.